연구성과로 돌아가기

2022 연구성과별 연구자 정보 (1579 / 2879)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Chon, Young Eun Chon, YE 1 Cha Univ, Cha Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Park, Soo Young Park, SY 2 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Kim, Seung Up Kim, SU 3 Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea L-4239-2013 Kim, Sun 0000-0002-9658-8050 Kim, Seung Up beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Kim, Seung Up Kim, SU 3 Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea L-4239-2013 Kim, Sun 0000-0002-9658-8050 Kim, Seung Up beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Kim, Seung Up Kim, SU 3 Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea L-4239-2013 Kim, Sun 0000-0002-9658-8050 Kim, Seung Up beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Hong, Han Pyo Hong, HP 4 Yonsei Univ Wonju Coll Med, Big Data Ctr, Dept Stat, Wonju, South Korea KHU-7470-2024 Hong, Hanpyo 0000-0002-0573-4527 Hong, Hanpyo beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Jae Seung Lee, JS 5 Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea KHT-9575-2024 LEE, JAE SEUNG 0000-0002-2371-0967 Lee, Jae Seung beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Jae Seung Lee, JS 5 Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea KHT-9575-2024 LEE, JAE SEUNG 0000-0002-2371-0967 Lee, Jae Seung beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Jae Seung Lee, JS 5 Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea KHT-9575-2024 LEE, JAE SEUNG 0000-0002-2371-0967 Lee, Jae Seung beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Hye Won Lee, HW 6 Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea D-9081-2016 Lee, Hye 0000-0002-3552-3560 Lee, Hye Won beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Hye Won Lee, HW 6 Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea D-9081-2016 Lee, Hye 0000-0002-3552-3560 Lee, Hye Won beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Lee, Hye Won Lee, HW 6 Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea D-9081-2016 Lee, Hye 0000-0002-3552-3560 Lee, Hye Won beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Kim, Mi Na Kim, MN 7 Cha Univ, Cha Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea 0000-0001-5381-230X Kim, Mi Na beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Park, Jun Yong Park, JY 8 Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea H-7127-2019 Park, Jun 0000-0001-6324-2224 Park, Jun Yong beomkkim@yuhs.ac;
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Park, Jun Yong Park, JY 8 Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea H-7127-2019 Park, Jun 0000-0001-6324-2224 Park, Jun Yong beomkkim@yuhs.ac;
페이지 이동: